Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
Last month, the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) jointly hosted a public meeting of the interagency “Strike ...
Live news: US Federal Trade Commission accuses top social media platforms of user surveillance on facebook (opens in a new window) Live news: US Federal Trade Commission accuses top ...
Eight U.S. senators on Tuesday urged the Department of Justice and Federal Trade Commission to undertake an antitrust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback